Basic fibroblast growth factor-saporin mitotoxin. In vitro studies of its cell-killing activity and of substances that alter that activity.
Martineau
D
D
Department of Molecular and Cellular Growth Biology, Whittier Institute for Diabetes and Endocrinology, Scripps Memorial Hospital, La Jolla, California 92037.
Lappi
D A
DA
Amburn
E
E
Baird
A
A
D000818:Animals; D016923:Cell Death / Q000187:drug effects; D002478:Cells, Cultured; D006224:Cricetinae; D003603:Cytotoxins / Q000037:antagonists & inhibitors / Q000737:chemistry*; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry*; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D000922:Immunotoxins; D066298:In Vitro Techniques; D009699:N-Glycosyl Hydrolases; D010940:Plant Proteins / Q000008:administration & dosage / Q000737:chemistry*; D054789:Ribosome Inactivating Proteins, Type 1; D000076985:Saporins; D014407:Tumor Cells, Cultured
D003603:Cytotoxins; D000922:Immunotoxins; D010940:Plant Proteins; D054789:Ribosome Inactivating Proteins, Type 1; D016222:Fibroblast Growth Factor 2; D006493:Heparin; D009699:N-Glycosyl Hydrolases; D000076985:Saporins